Elodie Valade is a Consultant at SGS Exprimo. Elodie obtained a Pharmacy degree (Pharm.D) and a M.S. degree in Pharmacokinetics from the Paris Descartes University, France in 2012. Thereafter, in 2015, she defended her Ph.D entitled “Treatment and Prevention of Transmission of HIV Infection: Pharmacokinetic analysis of emtricitabine by a population approach”. During this period, her research focused on the population pharmacokinetic modelling of one antiretroviral drug in specific populations (renal insufficiency patients, pregnant women) and in specific virus reservoirs (male genital tract). In 2016, Elodie joined the Global Clinical Pharmacology department of Johnson & Johnson in Beerse, Belgium, where she worked more than 2 years as a Postdoc Researcher. She was responsible for population pharmacokinetic and pharmacodynamic modelling and simulation activities supporting drug development, mainly in infectious diseases and oncology therapeutic areas. She was also particularly involved in the evaluation of cardiovascular safety (QT modelling) for several compounds. Elodie contributed to a registration dossier for a new drug application and is author of 14 original research papers in the fields of pharmacokinetic/pharmacodynamic modelling. Elodie joined SGS Exprimo in March 2019 and is based in Salamanca, Spain.